Search research articles
Contact Us
Filters
Showing results (1321-1330 of 1,467) with videos related to
Page
of 147
Sort By:
Journal of Medicinal Chemistry
|
April 26, 2014
Selectively promiscuous opioid ligands: discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinity
Vinod Kumar, Irna E Ridzwan, Konstantinos Grivas, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme
|
August 3, 2013
Physiologic responses to a thermogenic nutritional supplement at rest, during low-intensity exercise, and during recovery from exercise in college-aged women
Haley C Bergstrom, Terry J Housh, Daniel A Traylor, et al.
Science (New York, N.Y.)
|
March 30, 2013
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma
Peter W Lewis, Manuel M Müller, Matthew S Koletsky, et al.
International Journal of Sports Medicine
|
September 27, 2014
The rate of torque development: a unique, non-invasive indicator of eccentric-induced muscle damage?
N D M Jenkins, T J Housh, D A Traylor, et al.
Parasites & Vectors
|
May 17, 2017
Socio-demographic determinants of Toxoplasma gondii seroprevalence in migrant workers of Peninsular Malaysia
Norhidayu Sahimin, Yvonne A L Lim, Farnaza Ariffin, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
S W Lewis, L Davies, P B Jones, et al.
Acta Neuropathologica
|
September 10, 2014
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
Sriram Venneti, Mariarita Santi, Michelle Madden Felicella, et al.
JAMA Network Open
|
February 29, 2024
Disparities in Patient Portal Use Among Adults With Chronic Conditions
Esther Yoon, Scott Hur, Lauren Opsasnick, et al.
Journal of Medicinal Chemistry
|
August 28, 1998
3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy
S M Husbands, J Sadd, J H Broadbear, et al.
Cancer Research
|
August 26, 2024
CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression
Michael W Lewis, Caitlin M King, Kamila Wisniewska, et al.
Page
of 147
Search research articles
Search
Showing results (1321-1330 of 1,467) with videos related to
Sort By:
Page
of 147
Journal of Medicinal Chemistry
|
April 26, 2014
Selectively promiscuous opioid ligands: discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinity
Vinod Kumar, Irna E Ridzwan, Konstantinos Grivas, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme
|
August 3, 2013
Physiologic responses to a thermogenic nutritional supplement at rest, during low-intensity exercise, and during recovery from exercise in college-aged women
Haley C Bergstrom, Terry J Housh, Daniel A Traylor, et al.
Science (New York, N.Y.)
|
March 30, 2013
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma
Peter W Lewis, Manuel M Müller, Matthew S Koletsky, et al.
International Journal of Sports Medicine
|
September 27, 2014
The rate of torque development: a unique, non-invasive indicator of eccentric-induced muscle damage?
N D M Jenkins, T J Housh, D A Traylor, et al.
Parasites & Vectors
|
May 17, 2017
Socio-demographic determinants of Toxoplasma gondii seroprevalence in migrant workers of Peninsular Malaysia
Norhidayu Sahimin, Yvonne A L Lim, Farnaza Ariffin, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
S W Lewis, L Davies, P B Jones, et al.
Acta Neuropathologica
|
September 10, 2014
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
Sriram Venneti, Mariarita Santi, Michelle Madden Felicella, et al.
JAMA Network Open
|
February 29, 2024
Disparities in Patient Portal Use Among Adults With Chronic Conditions
Esther Yoon, Scott Hur, Lauren Opsasnick, et al.
Journal of Medicinal Chemistry
|
August 28, 1998
3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy
S M Husbands, J Sadd, J H Broadbear, et al.
Cancer Research
|
August 26, 2024
CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression
Michael W Lewis, Caitlin M King, Kamila Wisniewska, et al.
Page
of 147